• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

既往心绞痛:溶栓治疗后残余狭窄的预测因素。

Antecedent angina: a predictor of residual stenosis after thrombolytic therapy.

作者信息

Bergelson B A, Ruocco N A, Ryan T J, Hankin B R, Jacobs A K, Faxon D P

机构信息

Evans Memorial Department of Clinical Research, Boston University Medical Center, Massachusetts.

出版信息

J Am Coll Cardiol. 1989 Jul;14(1):91-5. doi: 10.1016/0735-1097(89)90057-0.

DOI:10.1016/0735-1097(89)90057-0
PMID:2500473
Abstract

Patients with a significant residual stenosis after thrombolytic therapy are believed by many to be at increased risk for repeat ischemic events and may be candidates for prompt angiography and revascularization. To test the hypothesis that patients with antecedent angina (Canadian classes I to IV, greater than or equal to 24 h before myocardial infarction) are more likely to have a significant residual stenosis (greater than or equal to 60% diameter reduction) than are those without antecedent angina, the coronary angiograms of 82 consecutive patients undergoing routine angiography after thrombolytic therapy were reviewed. Compared with the patients without antecedent angina, the group with antecedent angina had an increased mean stenosis (74% versus 58%) and more multivessel disease (44% versus 5%). The sensitivity and specificity of a clinical history of antecedent angina predicting the presence of a significant residual stenosis were 75% and 96%, respectively; the positive predictive accuracy was 98%. These data suggest that antecedent angina can be used to identify a high risk subgroup whose condition may warrant routine coronary angiography.

摘要

许多人认为,溶栓治疗后存在明显残余狭窄的患者再次发生缺血事件的风险增加,可能需要及时进行血管造影和血运重建。为了验证先前有过心绞痛(加拿大心血管学会分级I至IV级,心肌梗死前24小时或更长时间)的患者比没有先前心绞痛的患者更有可能存在明显残余狭窄(直径缩小≥60%)这一假设,我们回顾了82例溶栓治疗后接受常规血管造影的连续患者的冠状动脉造影结果。与没有先前心绞痛的患者相比,有先前心绞痛的患者平均狭窄程度更高(74%对58%),多支血管病变更多(44%对5%)。先前心绞痛的临床病史预测存在明显残余狭窄的敏感性和特异性分别为75%和96%;阳性预测准确率为98%。这些数据表明,先前心绞痛可用于识别一个高危亚组,其病情可能需要进行常规冠状动脉造影。

相似文献

1
Antecedent angina: a predictor of residual stenosis after thrombolytic therapy.既往心绞痛:溶栓治疗后残余狭窄的预测因素。
J Am Coll Cardiol. 1989 Jul;14(1):91-5. doi: 10.1016/0735-1097(89)90057-0.
2
Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction Phase II (TIMI II).既往有心绞痛的急性心肌梗死患者溶栓治疗后采用侵入性策略与保守策略的比较。心肌梗死溶栓治疗II期(TIMI II)报告。
J Am Coll Cardiol. 1992 Dec;20(7):1445-51. doi: 10.1016/0735-1097(92)90435-p.
3
Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.既往有稳定型心绞痛的患者接受溶栓治疗后心肌梗死预后较差:从国际组织型纤溶酶原激活剂/链激酶死亡率试验中获得的经验。
J Am Coll Cardiol. 1992 Jul;20(1):36-41. doi: 10.1016/0735-1097(92)90134-9.
4
[Relation of angina pectoris before myocardial infarct to coronarographic findings after thrombolytic therapy].
Cas Lek Cesk. 1990 Jun 8;129(23):719-22.
5
Residual coronary stenoses and calculated transstenotic gradients after intravenous streptokinase versus tissue plasminogen activator.静脉注射链激酶与组织型纤溶酶原激活剂后残余冠状动脉狭窄及计算得出的跨狭窄梯度
Am Heart J. 1992 Jan;123(1):7-14. doi: 10.1016/0002-8703(92)90740-m.
6
Effects of thrombolytic therapy in unstable angina: clinical and angiographic results.溶栓治疗对不稳定型心绞痛的影响:临床及血管造影结果
J Am Coll Cardiol. 1988 Aug;12(2):301-9. doi: 10.1016/0735-1097(88)90398-1.
7
Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking.
J Am Coll Cardiol. 1990 Aug;16(2):340-8. doi: 10.1016/0735-1097(90)90583-b.
8
Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction.
Am J Cardiol. 1990 Sep 1;66(5):538-45. doi: 10.1016/0002-9149(90)90478-j.
9
Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
J Am Coll Cardiol. 1993 Sep;22(3):707-13. doi: 10.1016/0735-1097(93)90180-9.
10
Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.早期血管造影术无法预测溶栓后冠状动脉再闭塞:来自GUSTO血管造影研究的观察结果。链激酶和组织型纤溶酶原激活剂在闭塞冠状动脉中的全球应用。
J Am Coll Cardiol. 1994 Nov 15;24(6):1439-44. doi: 10.1016/0735-1097(94)90137-6.